Ghevaert, C., Herbert, N., Hawkins, L., Grehan, N., Cookson, P., Garner, S.F., Crisp-Hihn, A., Lloyd-Evans, P., Evans, A., Balan, K., Ouwehand, W.H., Armour, K.L., Clark, M.R. and Williamson, L.M. (2013) Recombinant HPA-1a Antibody Therapy for Treatment of Fetomaternal Alloimmune Thrombocytopenia: Proof of Principle in Human Volunteers. Blood, 122, 313-320.
http://dx.doi.org/10.1182/blood-2013-02-481887

has been cited by the following article:

• TITLE: Neonatal Alloimmune Thrombocytopenia Due to Maternal Anti HPA1a Antibodies: Case Report and Management of Subsequent Pregnancy

  AUTHORS: Verónica Serrano-dela Cruz, Alicia Martínez-Varea, María José Núñez-Valera, Antonio Abad-Carrascosa, Vicente Diago, Alfredo Perales-Marín

  KEYWORDS: Fetoneonatal Alloimmune Thrombocytopenia; Anti-HPA1a Antibodies

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.4 No.5, March 20, 2014

  ABSTRACT: Fetoneonatal alloimmune thrombocytopenia is an infrequent and severe disease that is unexpectedly found after an uncomplicated first pregnancy. Affected infants might show unexplained purpura, intracranial hemorrhage, and/or gastrointestinal or genitourinary hemorrhage. Nevertheless, in asymptomatic newborns the thrombocytopenia may be discovered incidentally. We describe a case report that highlights that the incidental diagnosis of FNAIT allows both properly managing the newborn, and detecting maternal anti-HPA1a antibodies in order to prevent the disease in subsequent pregnancies. A non-invasive treatment based on IVIgG allowed to this patient to prevent FNAIT in her second pregnancy.